These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26656319)

  • 1. Predictors of Incident ESRD among Patients with Primary Hyperoxaluria Presenting Prior to Kidney Failure.
    Zhao F; Bergstralh EJ; Mehta RA; Vaughan LE; Olson JB; Seide BM; Meek AM; Cogal AG; Lieske JC; Milliner DS;
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):119-26. PubMed ID: 26656319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Oxalate as a Predictor of Kidney Function Decline in a Primary Hyperoxaluria Cohort.
    Shah RJ; Vaughan LE; Enders FT; Milliner DS; Lieske JC
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.
    Waikar SS; Srivastava A; Palsson R; Shafi T; Hsu CY; Sharma K; Lash JP; Chen J; He J; Lieske J; Xie D; Zhang X; Feldman HI; Curhan GC;
    JAMA Intern Med; 2019 Apr; 179(4):542-551. PubMed ID: 30830167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.
    Singh P; Vaughan LE; Schulte PJ; Sas DJ; Milliner DS; Lieske JC
    Am J Kidney Dis; 2022 Sep; 80(3):373-382. PubMed ID: 35306035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral native nephrectomy to reduce oxalate stores in children at the time of combined liver-kidney transplantation for primary hyperoxaluria type 1.
    Lee E; Ramos-Gonzalez G; Rodig N; Elisofon S; Vakili K; Kim HB
    Pediatr Nephrol; 2018 May; 33(5):881-887. PubMed ID: 29243158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma oxalate in relation to eGFR in patients with primary hyperoxaluria, enteric hyperoxaluria and urinary stone disease.
    Perinpam M; Enders FT; Mara KC; Vaughan LE; Mehta RA; Voskoboev N; Milliner DS; Lieske JC
    Clin Biochem; 2017 Dec; 50(18):1014-1019. PubMed ID: 28764885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma oxalate and eGFR are correlated in primary hyperoxaluria patients with maintained kidney function-data from three placebo-controlled studies.
    Milliner DS; Cochat P; Hulton SA; Harambat J; Banos A; Dehmel B; Lindner E
    Pediatr Nephrol; 2021 Jul; 36(7):1785-1793. PubMed ID: 33515281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting kidney inflammation as a new therapy for primary hyperoxaluria?
    Martin-Higueras C; Ludwig-Portugall I; Hoppe B; Kurts C
    Nephrol Dial Transplant; 2019 Jun; 34(6):908-914. PubMed ID: 30169827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
    Milliner D; Hoppe B; Groothoff J
    Urolithiasis; 2018 Aug; 46(4):313-323. PubMed ID: 28718073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function.
    Hillebrand P; Hoppe B
    Pediatr Nephrol; 2020 Jul; 35(7):1227-1233. PubMed ID: 32274573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up.
    Garrelfs SF; Rumsby G; Peters-Sengers H; Erger F; Groothoff JW; Beck BB; Oosterveld MJS; Pelle A; Neuhaus T; Adams B; Cochat P; Salido E; Lipkin GW; Hoppe B; Hulton SA;
    Kidney Int; 2019 Dec; 96(6):1389-1399. PubMed ID: 31685312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.
    Mizusawa Y; Parnham AP; Falk MC; Burke JR; Nicol D; Yamanaka J; Lynch SV; Strong RW
    Clin Transplant; 1997 Oct; 11(5 Pt 1):361-5. PubMed ID: 9361924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
    Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
    Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.
    Bollée G; Cochat P; Daudon M
    Can J Kidney Health Dis; 2015; 2():31. PubMed ID: 26380104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure.
    Raju DL; Cantarovich M; Brisson ML; Tchervenkov J; Lipman ML
    Am J Kidney Dis; 2008 Jan; 51(1):e1-5. PubMed ID: 18155525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End Points for Clinical Trials in Primary Hyperoxaluria.
    Milliner DS; McGregor TL; Thompson A; Dehmel B; Knight J; Rosskamp R; Blank M; Yang S; Fargue S; Rumsby G; Groothoff J; Allain M; West M; Hollander K; Lowther WT; Lieske JC
    Clin J Am Soc Nephrol; 2020 Jul; 15(7):1056-1065. PubMed ID: 32165440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
    Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation procedures in primary hyperoxaluria type 1.
    Latta A; Müller-Wiefel DE; Sturm E; Kemper M; Burdelski M; Broelsch CE
    Clin Nephrol; 1996 Jul; 46(1):21-3. PubMed ID: 8832145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.